Natural killer cell cytotoxicity and paternal lymphocyte immunization in women with recurrent spontaneous abortions. 1998

J Y Kwak, and A Gilman-Sachs, and M Moretti, and K D Beaman, and A E Beer
FUHS/The Chicago Medical School, Department of Microbiology and Immunology, North Chicago, Illinois 60064, USA.

OBJECTIVE Natural killer (NK)-cell cytotoxicity in women undergoing lymphocyte immunization prior to and following treatment was investigated. METHODS A cohort of 33 women with a history of two or more recurrent spontaneous abortions was prospectively studied. NK-cell cytotoxicity was determined at effector-to-target ratios of 50:1 and 25:1. Peripheral blood CD56+ NK-cell, CD19+ B-cell, CD19+/5+ B-1-cell, and CD3+ pan T-cell levels were studied by flow cytometry before and after lymphocyte immunization treatment. Maternal antipaternal T- and B-cell antibody levels were measured before and after lymphocyte immunization by flow cytometric analysis. Paternal lymphocyte immunizations were given two times with a 4-week interval. Post-lymphocyte immunization testing was done 4 weeks after the second lymphocyte immunization. The controls were 8 normal healthy women. NK assays were done twice with an interval of 8 weeks. RESULTS NK-cell activity at effector-to-target ratios of 50:1 (P = 0.005) and 25:1 (P = 0.001) were significantly suppressed after lymphocyte immunization. CD3+ pan T-cell levels after lymphocyte immunization were significantly increased compared with levels before lymphocyte immunization (P = 0.008). CD56+ NK-cell levels were significantly suppressed after lymphocyte immunization (P = 0.016). There was no correlation between changes in NK cytotoxicity and differences in antipaternal lymphocyte antibody levels before or after lymphocyte immunization. CONCLUSIONS Lymphocyte immunization suppresses NK-cell cytotoxicity and CD56+ NK-cell levels and increases the peripheral blood CD3+ T-cell population in women with recurrent spontaneous abortions.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D007518 Isoantibodies Antibodies from an individual that react with ISOANTIGENS of another individual of the same species. Alloantibodies
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008297 Male Males
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D005220 Fathers Male parents, human or animal. Father
D005260 Female Females

Related Publications

J Y Kwak, and A Gilman-Sachs, and M Moretti, and K D Beaman, and A E Beer
February 1995, American journal of reproductive immunology (New York, N.Y. : 1989),
J Y Kwak, and A Gilman-Sachs, and M Moretti, and K D Beaman, and A E Beer
October 2008, European journal of obstetrics, gynecology, and reproductive biology,
J Y Kwak, and A Gilman-Sachs, and M Moretti, and K D Beaman, and A E Beer
March 2003, American journal of reproductive immunology (New York, N.Y. : 1989),
J Y Kwak, and A Gilman-Sachs, and M Moretti, and K D Beaman, and A E Beer
January 2011, Vojnosanitetski pregled,
J Y Kwak, and A Gilman-Sachs, and M Moretti, and K D Beaman, and A E Beer
June 2001, Human reproduction (Oxford, England),
J Y Kwak, and A Gilman-Sachs, and M Moretti, and K D Beaman, and A E Beer
November 2000, American journal of reproductive immunology (New York, N.Y. : 1989),
J Y Kwak, and A Gilman-Sachs, and M Moretti, and K D Beaman, and A E Beer
January 1990, Gynecologic and obstetric investigation,
J Y Kwak, and A Gilman-Sachs, and M Moretti, and K D Beaman, and A E Beer
December 2015, Neuro endocrinology letters,
J Y Kwak, and A Gilman-Sachs, and M Moretti, and K D Beaman, and A E Beer
November 2000, American journal of reproductive immunology (New York, N.Y. : 1989),
Copied contents to your clipboard!